Tag: biopharma
Aragen secures $100 Mn investment from Quadria Capital
With Quadria acquiring a minority stake in the company, investment will fund expansion to meet rising demand for CRDMO services
Eli Lilly to establish new global capability centre in Hyderabad, hire...
New centre expected to open in mid-2025 will drive innovation and technological advancement
Aragen receives Platinum Medal from EcoVadis for its sustainability initiatives
First Indian company to receive this highest global sustainability recognition
BioVoice eMagazine January 2025 | Issue 1 | Volume 6
The Cover Story features flashback 2024 and a collective vision of industry leaders for 2025. Read interviews of Dr Abdelaziz Toumi, CEO, Lupin Manufacturing Solutions; and Dr Anil Gulati, Chairman and CEO, Pharmazz Inc. Expert Insights by Anindith Reddy, Managing Director, Enliva (Wadi Surgicals). Special Story on Agritech Startups.
Budget 2025: OPPI seeks special incentives
Policy-level clarifications, such as expanded exemptions for life-saving drugs and oncology medications from import duty are vital for reducing treatment costs
Lupin acquires Huminsulin from Lilly to enhance Diabetes portfolio
The Huminsulin range of products is indicated for the treatment of type 1 and type 2 diabetes mellitus to improve blood sugar control in both adults and children
Indian pharma companies focus on innovative research in foreign countries through...
According to GlobalData’s Pharmaceutical Intelligence Center, as of 20 December 2024, there are a total of 16 drugs in the pipeline from Phase I to Phase III
SPARC signs LOI with UCSF & Tiller Therapeutics for pre-clinical oncology...
Asset developed in three-year partnership between SPARC and UCSF. SPARC to receive 55% equity in Tiller Therapeutic
Dr Reddy’s enhances infrastructure for tribal welfare school & college in...
These institutions, run by the state government, provide education to 480 school students and 160 college students, primarily girls from tribal areas across the state
Facing the Silent Threat: How AMR Imperils Our Future
Antimicrobial resistance poses a silent yet formidable threat to global health, economic stability, and societal well-being, writes Dr Prabhu Vinayagam






























































